AT484514T

Derivatives of isoindigo, indigo and indirubin and use in treating cancer

Abstract

The compound (derivative of iso indigo) called NATURA is useful although a patient's general health is promoted, and when it prevents or treats cancer, it is specifically useful. Related iso indigo of this compound and others, indigo, and the Inn Jill Bin derivative are designed so that the biological activity or bioavailability of a compound may increase. The method of compounding these derivatives is also indicated. Furthermore, the medicine composite including the carrier who is therapeutically permitted as at least one sort and medicine of an effective quantity of these derivatives, and gets is also indicated. The method for using these medicine composites and compounds is indicated, and the animal suffered from solid tumor cancer at this time is therapeutically medicated with an effective quantity. An animal can be medicated with the medicine composite or compound of the present invention until desired medical treatment or a result is attained.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

57 members in 13 offices

This recordMember, by publication datePriority claim3 more offices are in the list below

Priority claims3

Priority claims
DocumentOfficeKindDate
2158901United States of AmericaA
40726702United States of AmericaP
0239866United States of AmericaW

Members57

Family members, oldest first
DocumentOfficeKind
US6566341B1United States of AmericaB1
CA2469649A1CanadaA1
WO03051900A1World Intellectual Property Organization (WIPO)A1
AU2002357191A1AustraliaA1
EP1458734A1European Patent Office (EPO)A1
US2004225002A1United States of AmericaA1
JP2005516938AJapanA
US2005154046A1United States of AmericaA1
CA2547963A1CanadaA1
CA2871459A1CanadaA1
WO2005069933A2World Intellectual Property Organization (WIPO)A2
US6933315B2United States of AmericaB2
US2005197381A1United States of AmericaA1
WO2005069933A3World Intellectual Property Organization (WIPO)A3
EP1706112A2European Patent Office (EPO)A2
US2007027203A1United States of AmericaA1
JP2007522114AJapanA
EP1458734A4European Patent Office (EPO)A4
EP1706112A4European Patent Office (EPO)A4
US7582670B2United States of AmericaB2
US2009325895A1United States of AmericaA1
US2010098702A1United States of AmericaA1
EP1458734B1European Patent Office (EPO)B1
AT484514TThis recordAustriaT
ATE484514T1AustriaT1
DE60237993D1GermanyD1
US7855223B2United States of AmericaB2
CA2469649CCanadaC
US2011160157A1United States of AmericaA1
EP2351564A1European Patent Office (EPO)A1
US2012058121A1United States of AmericaA1
US2012070518A1United States of AmericaA1
HK1160393AHong Kong, ChinaA
JP2012176956AJapanA
US2013022609A1United States of AmericaA1
US8394847B2United States of AmericaB2
US2013178439A1United States of AmericaA1
US8563525B2United States of AmericaB2
JP5383977B2JapanB2
EP1706112B1European Patent Office (EPO)B1
PT1706112EPortugalE
US8748475B2United States of AmericaB2
HRP20140536T1CroatiaT1
PL1706112T3PolandT3
RS53372BSerbiaB
US2014356373A1United States of AmericaA1
CA2547963CCanadaC
JP2015071626AJapanA
US9023885B2United States of AmericaB2
US9040574B2United States of AmericaB2
US2015231115A1United States of AmericaA1
EP2351564B1European Patent Office (EPO)B1
US2015335617A1United States of AmericaA1
EP3020400A1European Patent Office (EPO)A1
JP5969255B2JapanB2
HK1220612AHong Kong, ChinaA
US9962400B2United States of AmericaB2